Mice bearing tumors were treated with 200 mg/kg EZH2 inhibitor EPZ-6438 per day, a dose that exhibited dramatic tumor growth inhibition in the preclinical lymphoma xenograft models, and then xenografts were collected [38]. The gene discussed is EZH2; the disease is neoplasm.